XML 22 R11.htm IDEA: XBRL DOCUMENT
v3.25.3

Earnings Per Share | 9 Months Ended
--- | ---
Sep. 30, 2025
Earnings Per Share [Abstract] |
Earnings Per Share | Earnings Per Share There are no convertible securities which would affect the numerator in calculating basic and diluted earnings per share; therefore, net income as presented on the Consolidated Statements of Income is used as the numerator. The following table sets forth the composition of the weighted-average common shares (denominator) used in the basic and diluted earnings per share computation:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2025 | 2024 |  | 2025 | 2024
(Dollars in thousands, except share and per share data) |  |  |  |  |
Net (Loss) Income | $ | (5,696) |  | $ | 3,219 |  |  | $ | 164 |  | $ | 10,065 |
Weighted-Average Basic Common Shares Outstanding | 4,985,188 |  | 5,137,586 |  |  | 5,044,012 |  | 5,136,546 |
Dilutive Effect of Common Stock Equivalents (Stock Options and Restricted Stock) | 334,406 |  | 209,164 |  |  | 313,161 |  | 192,064 |
Weighted-Average Diluted Common Shares and Common Stock Equivalents Outstanding | 5,319,594 |  | 5,346,750 |  |  | 5,357,173 |  | 5,328,610 |
(Loss) Earnings Per Share: |  |  |  |  |
Basic | $ | (1.14) |  | $ | 0.63 |  |  | $ | 0.03 |  | $ | 1.96 |
Diluted | (1.07) |  | 0.60 |  |  | 0.03 |  | 1.89 |
The dilutive effect on weighted average diluted common shares outstanding is the result of outstanding stock options and nonvested restricted stock. The following table presents for the periods indicated (a) options to purchase shares of common stock that were outstanding but not included in the computation of earnings per share because the options’ exercise price was greater than the average market price of the common shares for the period, and (b) shares of restricted stock awards that were not included in the computation of diluted earnings per share because the hypothetical repurchase of shares under the treasury stock method exceeded the weighted average nonvested restricted awards, therefore the effects would be anti-dilutive.
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2025 | 2024 |  | 2025 | 2024
Stock Options | — |  | 275,208 |  |  | 21,245 |  | 292,308 |
Restricted Stock | — |  | — |  |  | — |  | — |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration